Sign In
Buy ATRS
$5.59
+0 (+0%)
At Close: Jul 20, 2022
Edited Transcript of BCSF.N earnings conference call or presentation 27-Feb-20 1:30pm GMT
06:44am, Sunday, 15'th Mar 2020
Q4 2019 Bain Capital Specialty Finance Inc Earnings Call
Global Needle Free Injection System Market 2020 - Technology Landscape, Trends & Opportunities - ResearchAndMarkets.com
01:23pm, Thursday, 12'th Mar 2020
The "Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market" report has been added to ResearchAndMarkets.com's offering.
Barclays PLC Buys 90,830 Shares of Antares Pharma Inc (NASDAQ:ATRS)
08:56am, Thursday, 12'th Mar 2020
Barclays PLC grew its stake in Antares Pharma Inc (NASDAQ:ATRS) by 90.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutiona
Spaceflight Readies 28 Payloads for Inaugural Rideshare Launch on Arianespace’s Vega
12:00pm, Monday, 09'th Mar 2020
Spaceflight today announced it is providing mission management and rideshare integration services for four organizations on Arianespace’s first dedicated rideshare mission on its Vega launch vehicle
Barrier-Breaking Architect Says It’s Time for More Women in the Field
10:59am, Monday, 09'th Mar 2020Zacks: Brokerages Anticipate Antares Pharma Inc (NASDAQ:ATRS) Will Post Quarterly Sales of $30.90 Million
05:58am, Monday, 09'th Mar 2020
Equities analysts expect that Antares Pharma Inc (NASDAQ:ATRS) will post $30.90 million in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Antares Pharma�
Starwatch: blood-red Antares, the brightest star in Scorpio
09:30pm, Sunday, 08'th Mar 2020
This week will offer an opportunity to see the giant star that is 750 times the diameter of the sun
Antares Pharma Inc Expected to Post Q2 2020 Earnings of $0.00 Per Share (NASDAQ:ATRS)
06:54am, Sunday, 08'th Mar 2020
Antares Pharma Inc (NASDAQ:ATRS) – Jefferies Financial Group lifted their Q2 2020 earnings per share estimates for shares of Antares Pharma in a report issued on Tuesday, March 3rd. Jefferies Financ
Antares Pharma Inc (NASDAQ:ATRS) Shares Sold by New York State Common Retirement Fund
11:54am, Saturday, 07'th Mar 2020
New York State Common Retirement Fund cut its stake in shares of Antares Pharma Inc (NASDAQ:ATRS) by 25.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1
Q1 2021 EPS Estimates for Antares Pharma Inc (NASDAQ:ATRS) Boosted by Piper Sandler
09:20am, Saturday, 07'th Mar 2020
Antares Pharma Inc (NASDAQ:ATRS) – Investment analysts at Piper Sandler boosted their Q1 2021 earnings per share (EPS) estimates for Antares Pharma in a research note issued on Tuesday, March 3rd. P
Antares Pharma (NASDAQ:ATRS) Stock Price Down 6.6%
08:44am, Saturday, 07'th Mar 2020
Antares Pharma Inc (NASDAQ:ATRS) traded down 6.6% on Friday . The stock traded as low as $3.17 and last traded at $3.24, 1,843,471 shares changed hands during trading. An increase of 18% from the aver
Piper Sandler Analysts Cut Earnings Estimates for Antares Pharma Inc (NASDAQ:ATRS)
07:40am, Friday, 06'th Mar 2020
Antares Pharma Inc (NASDAQ:ATRS) – Analysts at Piper Sandler reduced their Q2 2020 earnings per share estimates for shares of Antares Pharma in a report released on Tuesday, March 3rd. Piper Sandler
Antares Pharma (NASDAQ:ATRS) Shares Gap Up After Analyst Upgrade
06:40am, Friday, 06'th Mar 2020
Antares Pharma Inc (NASDAQ:ATRS)’s stock price gapped up prior to trading on Thursday after Raymond James raised their price target on the stock from $5.65 to $6.00. The stock had previously closed
Antares Pharma (NASDAQ:ATRS) Shares Up 8.7% Following Analyst Upgrade
06:22am, Friday, 06'th Mar 2020
Antares Pharma Inc (NASDAQ:ATRS)’s share price shot up 8.7% during trading on Wednesday after Raymond James raised their price target on the stock from $5.65 to $6.00. Raymond James currently has a
Antares Pharma (NASDAQ:ATRS) Releases Earnings Results
04:36pm, Thursday, 05'th Mar 2020
Antares Pharma (NASDAQ:ATRS) posted its earnings results on Tuesday. The specialty pharmaceutical company reported $0.03 EPS for the quarter, Bloomberg Earnings reports. The business had revenue of $3
